The human paraoxonase‐1 phenotype modifies the effect of statins on paraoxonase activity and lipid parameters

Abstract

The PON1 phenotype may be a novel predictive factor for the effectiveness of statin treatment on PON1 activity and serum lipid levels; however, different types of statins may exert different effects on these parameters.